Avalon GloboCare Corp.

Avalon GloboCare Corp. is a technology-innovation company focused on developing products and services for consumer health and technology markets. The company operates through two business segments. The first segment is consumer health technology, which distributes the Keto Air breathalyzer device. This non-invasive consumer breathalyzer measures ketosis levels and is sold in North America. The Keto Air device has an FDA registration number. It allows users to determine their state and level of nutritional ketosis by exhaling into a compact, pen-like breathalyzer. Ketosis is a metabolic state where the body burns fat instead of carbohydrates, often associated with low-carbohydrate and ketogenic diets. The Keto Air device offers a convenient, reusable, and non-invasive testing experience, improving upon methods like urine test strips or earlier breathalyzers requiring cartridge replacements. Avalon GloboCare Corp. entered into an exclusive North American distribution agreement for the Keto-Air technology and device in 2024. The second segment is artificial intelligence content technology. Through this segment, the company develops and commercializes an AI-driven, short-form video generation platform. This platform is operated by Avalon Quantum AI, LLC, a wholly owned subsidiary formed in connection with the acquisition of RPM Interactive, Inc. in December 2025. The company is also actively seeking complementary bolt-on AI acquisitions that could generate near-term revenue to supplement current operations.